Login to Your Account



Clinic Roundup


Wednesday, September 28, 2011
Sunesis Pharmaceuticals Inc., of South San Francisco, began a Phase I trial of its cancer candidate, MLN2480, sponsored by Millennium Pharmaceuticals Inc., of Cambridge, Mass., a unit of Takeda Pharmaceuticals Co. Ltd.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription